TYRA vs UPC

Tyra Biosciences, Inc. vs Universe Pharmaceuticals Inc — Valuation Comparison 2026

TYRA

Pharmaceutical Preparations
Tyra Biosciences, Inc.
Quality
4.3
out of 10
Value Trap
18
SAFE
Price
$33.41
Last close
Models
7/13
Active
VS

UPC

Pharmaceutical Preparations
Universe Pharmaceuticals Inc
Quality
1.5
out of 10
Value Trap
15
SAFE
Price
$3.50
Last close
Models
4/13
Active

Model-by-Model Comparison

ModelType TYRA Fair ValueTYRA Upside UPC Fair ValueUPC Upside
Bayesian DCF Intrinsic $9.65 -71.1% $0.53 -84.7%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $5.32 -84.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $9.06 +235.7%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TYRA vs UPC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TYRA vs UPC — Which Stock Is More Undervalued?

TYRA scores higher with a 4.3/10 quality rating vs UPC's 1.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tyra Biosciences, Inc. (TYRA) and Universe Pharmaceuticals Inc (UPC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TYRA currently trades at $33.41 with a QOC of 4.3/10, while UPC trades at $3.50 with a QOC of 1.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).